Association between prehospital shock index and mortality among patients with COVID-19 disease. 2022

Romain Jouffroy, and Elise Brami, and Marine Scannavino, and Yann Daniel, and Kilian Bertho, and Amandine Abriat, and Marina Salomé, and Sabine Lemoine, and Daniel Jost, and Bertrand Prunet, and Stéphane Travers
Paris Fire Brigade, Emergency Medicine dpt, 1 place Jules Renard, 75017 Paris, France. Electronic address: romain.jouffroy@pompiersparis.fr.

There exists a need for prognostic tools for the early identification of COVID-19 patients requiring intensive care unit (ICU) admission and mortality. Here we investigated the association between a clinical (initial prehospital shock index (SI)) and biological (initial prehospital lactatemia) tool and the ICU admission and 30-day mortality among COVID-19 patients cared for in the prehospital setting. We retrospectively analysed COVID-19 patients initially cared for by a Paris Fire Brigade advanced (ALS) or basic life support (BLS) team in the prehospital setting between 2020, March 08th and 2020, May 30th. We assessed the association between prehospital SI and prehospital lactatemia and ICU admission and mortality using logistic regression model analysis after propensity score matching with Inverse Probability Treatment Weighting (IPTW) method. Covariates included in the IPTW propensity analysis were: age, sex, body mass index (BMI), initial respiratory rate (iRR), initial pulse oximetry without (SpO2i) and with oxygen supplementation (SpO2i.O2), initial Glasgow coma scale (GCSi) value, initial prehospital SI and initial prehospital lactatemia. We analysed 410 consecutive COVID-19 patients [254 males (62%); mean age, 64 ± 18 years]. Fifty-seven patients (14%) deceased on the scene, of whom 41 (72%) were male and were significantly older (71 ± 12 years vs. 64 ± 19 years; P 〈10-3). Fifty-three patients (15%) were admitted in ICU and 39 patients (11%) were deceased on day-30. The mean prehospital SI value was 1.5 ± 0.4 and the mean prehospital lactatemia was 2.0 ± 1.7 mmol.l-1. Multivariate logistic regression analysis on matched population after IPTW propensity analysis reported a significant association between ICU admission and age (adjusted Odd-Ratio (aOR), 0.90; 95% confidence interval (95%CI): 0.93-0.98;p = 10-3), SpO2i.O2 (aOR, 1.10; 95%CI: 1.02-1.20;p = 0.002) and BMI (aOR, 1.09; 95% CI: 1.03-1.16;p = 0.02). 30-day mortality was significantly associated with SpO2i.O2 (aOR, 0.92; 95% CI: 0.87-0.98;p = 0.01 P < 10-3) and GCSi (aOR, 0.90; 95% CI: 0.82-0.99;p = 0.04). Neither prehospital SI nor prehospital lactatemia were associated with ICU admission and 30-day mortality. Neither prehospital initial SI nor lactatemia were associated with ICU admission and 30-day mortality among COVID-19 patients initially cared for by a Paris Fire Brigade BLS or ALS team. Further prospective studies are needed to confirm these preliminary results.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004632 Emergency Medical Services Services specifically designed, staffed, and equipped for the emergency care of patients. Emergency Care,Emergency Health Services,Emergicenters,Prehospital Emergency Care,Emergency Care, Prehospital,Emergency Services, Medical,Medical Services, Emergency,Services, Emergency Medical,Emergency Health Service,Emergency Medical Service,Emergency Service, Medical,Emergicenter,Health Service, Emergency,Health Services, Emergency,Medical Emergency Service,Medical Emergency Services,Medical Service, Emergency,Service, Emergency Health,Service, Emergency Medical,Service, Medical Emergency,Services, Emergency Health,Services, Medical Emergency
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Romain Jouffroy, and Elise Brami, and Marine Scannavino, and Yann Daniel, and Kilian Bertho, and Amandine Abriat, and Marina Salomé, and Sabine Lemoine, and Daniel Jost, and Bertrand Prunet, and Stéphane Travers
September 2022, The American journal of emergency medicine,
Romain Jouffroy, and Elise Brami, and Marine Scannavino, and Yann Daniel, and Kilian Bertho, and Amandine Abriat, and Marina Salomé, and Sabine Lemoine, and Daniel Jost, and Bertrand Prunet, and Stéphane Travers
April 2023, The American journal of emergency medicine,
Romain Jouffroy, and Elise Brami, and Marine Scannavino, and Yann Daniel, and Kilian Bertho, and Amandine Abriat, and Marina Salomé, and Sabine Lemoine, and Daniel Jost, and Bertrand Prunet, and Stéphane Travers
May 2022, BMC emergency medicine,
Romain Jouffroy, and Elise Brami, and Marine Scannavino, and Yann Daniel, and Kilian Bertho, and Amandine Abriat, and Marina Salomé, and Sabine Lemoine, and Daniel Jost, and Bertrand Prunet, and Stéphane Travers
May 2024, European journal of medical research,
Romain Jouffroy, and Elise Brami, and Marine Scannavino, and Yann Daniel, and Kilian Bertho, and Amandine Abriat, and Marina Salomé, and Sabine Lemoine, and Daniel Jost, and Bertrand Prunet, and Stéphane Travers
November 2023, The Journal of emergency medicine,
Romain Jouffroy, and Elise Brami, and Marine Scannavino, and Yann Daniel, and Kilian Bertho, and Amandine Abriat, and Marina Salomé, and Sabine Lemoine, and Daniel Jost, and Bertrand Prunet, and Stéphane Travers
February 2021, The American journal of emergency medicine,
Romain Jouffroy, and Elise Brami, and Marine Scannavino, and Yann Daniel, and Kilian Bertho, and Amandine Abriat, and Marina Salomé, and Sabine Lemoine, and Daniel Jost, and Bertrand Prunet, and Stéphane Travers
January 2022, Journal of thrombosis and thrombolysis,
Romain Jouffroy, and Elise Brami, and Marine Scannavino, and Yann Daniel, and Kilian Bertho, and Amandine Abriat, and Marina Salomé, and Sabine Lemoine, and Daniel Jost, and Bertrand Prunet, and Stéphane Travers
January 2023, Frontiers in endocrinology,
Romain Jouffroy, and Elise Brami, and Marine Scannavino, and Yann Daniel, and Kilian Bertho, and Amandine Abriat, and Marina Salomé, and Sabine Lemoine, and Daniel Jost, and Bertrand Prunet, and Stéphane Travers
February 2021, The Journal of infection,
Romain Jouffroy, and Elise Brami, and Marine Scannavino, and Yann Daniel, and Kilian Bertho, and Amandine Abriat, and Marina Salomé, and Sabine Lemoine, and Daniel Jost, and Bertrand Prunet, and Stéphane Travers
June 2020, Mayo Clinic proceedings,
Copied contents to your clipboard!